GP-Act III Acquisition Common Stock

GP-Act III Acquisition (GPAT) currently reports a common stock of $620M as of March 2026. That compares with $600M in the prior-year period — up 3.9% year over year. Use the charts on this page to explore GP-Act III Acquisition's common stock history and peer comparisons.

GP-Act III Acquisition's common stock increased from $600M to $620M — a 3.9% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

GP-Act III Acquisition reported $620M in common stock as of March 2026. That compares with $600M in the prior-year period — up 3.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current common stock of $620M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for GP-Act III Acquisition, and consider following GPAT for alerts when major investors trade the stock.